Why the study?
Driving regulations for patients with cardiac conditions at high risk of sudden incapacitation vary significantly across countries, and the assumptions underlying risk quantification may no longer reflect modern driving.
Highlights the significant global variation in driving restrictions for patients with arrhythmogenic conditions and advocates for updated, individualized risk assessments.
May warrant individualized driving advice over uniform rules; leaves open need for prospective validation of updated risk models.
The ability to drive is a highly valued freedom in the developed world. Sudden incapacitation while driving can result in injury or death for the driver and passengers or bystanders. Cardiovascular conditions are a primary cause for sudden incapacitation and regulations have long existed to restrict driving for patients with cardiac conditions at high risk of sudden incapacitation. Significant variation occurs between these rules in different countries and legislatures. Quantification of the potential risk of harm associated with various categories of drivers has attempted to make these regulations more objective. The assumptions on which these calculations are based are now old and less likely to reflect the reality of modern driving. Ultimately, a more individual assessment of risk with a combined assessment of the medical condition and the patient's driving behaviour may be appropriate. The development of driverless technologies may also have an impact on decision making in this field.
No takes yet. Share an insight, caveat, or question.
Mǎrgulescu et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: